Tanfac Industries: Powering Growth with Fluorine Chemistry and Strategic Expansions

Tanfac Industries Limited, a seasoned player in fluorine chemistry, has demonstrated robust performance and strategic foresight, positioning itself for significant growth in high-value segments. The company's latest investor presentation highlights a strong financial year in FY25, marked by record revenues and profitability, alongside ambitious expansion projects that are already yielding results. With a clear focus on backward integration, product diversification, and securing long-term customer commitments, Tanfac is steadily transforming its operational landscape.

For the fiscal year 2025, Tanfac reported its highest-ever revenue from operations at ₹556.98 Crore, reflecting a substantial 47% year-on-year growth. This impressive top-line performance was complemented by a record EBITDA of ₹128.88 Crore, with a healthy margin of 23%, and a net profit (PAT) of ₹88.15 Crore, showcasing a remarkable 68% growth over the previous year. These strong financial metrics underscore the successful implementation of key projects, particularly the HF Expansion Project commissioned in October 2024, which significantly boosted production volumes. While the company maintained a healthy revenue level in Q3 FY26 and 9M FY26, it did experience some pressure on EBITDA margins, which stood at 15% and 16% respectively, primarily due to a spurt in key input material costs.

Strategic Initiatives Driving Future Growth

Tanfac's growth narrative is strongly supported by its strategic capital allocation and project execution. The company successfully doubled its Hydrofluoric Acid (HF) capacity from 14,850 MTPA to 29,700 MTPA with the commissioning of a new state-of-the-art HF unit in October 2024. This expansion, completed within time and projected cost, positions Tanfac as one of India's largest AHF facilities, enhancing in-house HF availability and supporting the production of high-value fluorine derivatives. This move is critical for improving cost efficiency, ensuring supply security, and strengthening integration across the value chain.

Further demonstrating its commitment to high-growth sectors, Tanfac commissioned both phases of its solar-grade Dilute Hydrofluoric Acid (DHF) facility in June and October 2025, each with a capacity of 10,000 MTPA. The DHF product has already been successfully sold to Indian solar wafer manufacturers after rigorous quality trials, establishing Tanfac as a key supplier in the burgeoning clean energy ecosystem. This initiative directly addresses the high-purity chemical needs of the photovoltaic and semiconductor sectors, which are experiencing rapid expansion.

Venturing into Refrigerant Gas and Long-Term Partnerships

A significant strategic move for Tanfac is its entry into the Refrigerant Gas (HFC-32) segment. The company announced an investment of ₹495 Crore for a 20,000 MTPA HFC-32 plant at its Cuddalore facility, with production targeted to commence by the end of Q3 FY27. This venture is underpinned by a substantial long-term supply agreement with a Japanese customer for 7,500 MTPA of Refrigerant Gas over seven years, valued at approximately ₹2,362 Crore. This agreement, effective from January 1, 2027, not only provides long-term revenue visibility but also strengthens Tanfac's domestic and export portfolio, reinforcing its position as a reliable global supplier of fluorinated chemicals.

Tanfac's R&D capabilities, complemented by its joint sector company status with TIDCO and Anupam Rasayan India Ltd., play a crucial role in its strategic advancements. The company's dedicated R&D laboratory at Cuddalore, staffed by a strong team of researchers, focuses on various fluorination techniques and organic synthesis reactions. This R&D prowess has led to the successful development of several products at the lab scale, including refrigerants and monomers, and the scaling up of various inorganic and organic products, demonstrating strong technical expertise and innovation.

Market Opportunities and Outlook

The company is well-positioned to capitalize on promising market opportunities in fluorochemicals. The global AHF market is projected to grow at a CAGR of 5.3% to 2.6 MMT by CY30P, while the Indian AHF market is expected to grow at 9.7% to 175 KT by FY31P. Similarly, the Solar DHF market presents a global CAGR of 15.0% and an Indian CAGR of 33.0%, reaching 300 KT globally and 80 KT in India by CY30P/FY31P, respectively. The HFC-32 market also shows robust growth, with a global CAGR of 5.0% and an Indian CAGR of 15.0%. Tanfac's strategic investments align perfectly with these growth trends, particularly in solar cells, refrigerants, and advanced intermediates.

Tanfac's commitment to operational excellence is further evidenced by its compliance with regulatory and environmental standards, including TPM Excellence Award from Japanese Institute of Plant Management, ISO 9001:2015, and 14001:2015 certifications. These certifications underscore the company's focus on quality and sustainable manufacturing practices.

In conclusion, Tanfac Industries is executing a well-defined strategy focused on capacity expansion, product diversification into high-value segments, and securing long-term customer relationships. Despite short-term margin pressures from input costs, the company's strong financial performance in FY25, coupled with its strategic initiatives in solar-grade DHF and HFC-32, positions it for sustained growth and enhanced market leadership in the fluorochemicals industry. The management's proactive approach to anticipating sector trends and investing in future-ready products reinforces investor confidence in its long-term trajectory.